These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

759 related items for PubMed ID: 18338833

  • 1. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Zhong S, Liu X, Tan WS.
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [Abstract] [Full Text] [Related]

  • 2. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF, Wang YG, Xiao T, Zhang KJ, Li GC, Gu JF, Chu L, Tang WH, Tan WS, Liu XY.
    Cancer Lett; 2009 Dec 28; 286(2):196-205. PubMed ID: 19564073
    [Abstract] [Full Text] [Related]

  • 3. [Specific antitumor effect of adeno-associated virus vector carrying TRAIL gene under the control of hTERT promoter].
    Qi R, Cai Y, Li BH, Lin ZX, Gu JF.
    Ai Zheng; 2008 Oct 28; 27(10):1026-33. PubMed ID: 18851780
    [Abstract] [Full Text] [Related]

  • 4. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice.
    Zhang Y, Ma H, Zhang J, Liu S, Liu Y, Zheng D.
    Life Sci; 2008 Jun 06; 82(23-24):1154-61. PubMed ID: 18485417
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y, Huang F, Cai H, Wu Y, He G, Tan WS.
    J Cancer Res Clin Oncol; 2010 Dec 06; 136(12):1827-37. PubMed ID: 20213096
    [Abstract] [Full Text] [Related]

  • 6. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 06; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 7. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
    Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC, Fang B.
    Clin Cancer Res; 2004 May 15; 10(10):3535-41. PubMed ID: 15161713
    [Abstract] [Full Text] [Related]

  • 8. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H, Liu Y, Liu S, Xu R, Zheng D.
    Hepatology; 2005 Dec 15; 42(6):1355-63. PubMed ID: 16317690
    [Abstract] [Full Text] [Related]

  • 9. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB, Zhou YL, Heng DF, Miao CH, Cao YL.
    Breast Cancer Res Treat; 2008 Jul 15; 110(2):283-95. PubMed ID: 17899369
    [Abstract] [Full Text] [Related]

  • 10. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W, Chu L, Han X, Liu X, Ren D.
    J Gene Med; 2008 Jun 15; 10(6):690-701. PubMed ID: 18338832
    [Abstract] [Full Text] [Related]

  • 11. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J, Andreeff M, Roth JA, Fang B.
    Gene Ther; 2002 Jan 15; 9(1):30-7. PubMed ID: 11850720
    [Abstract] [Full Text] [Related]

  • 12. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B.
    Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263
    [Abstract] [Full Text] [Related]

  • 13. [Construction of TRAIL gene eukaryotic expression vector modulated by hTERT gene core promoter and its effect on apoptosis of ovarian cancer cells].
    Li HM, Song TB, Yu YC, Cao YX, Wang HY, Song H, Zhang M.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar 01; 22(2):243-6. PubMed ID: 16507264
    [Abstract] [Full Text] [Related]

  • 14. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
    Kong BH, Song Y, Ma DX, Qu X, Jiang S.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun 01; 39(6):390-5. PubMed ID: 15312323
    [Abstract] [Full Text] [Related]

  • 15. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
    Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H, Srinivasula SM, Barna BP, Germano IM, Takakura M, Inoue M, Alnemri ES, Shay JW, Kyo S, Kondo S.
    Cancer Res; 2001 Aug 01; 61(15):5796-802. PubMed ID: 11479218
    [Abstract] [Full Text] [Related]

  • 16. Enforced expression of a truncated form of Bax-alpha (tBax) driven by human telomerase reverse transcriptase (hTERT) promoter sensitizes tumor cells to chemotherapeutic agents or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Toyota H, Kondo S, Kyo S, Mizuguchi J.
    Anticancer Res; 2006 Aug 01; 26(1A):99-105. PubMed ID: 16475685
    [Abstract] [Full Text] [Related]

  • 17. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J, Choi S, Hwang KS, Cho WK, Jung CR, Kwon ST, Im DS.
    J Gene Med; 2006 Feb 01; 8(2):163-74. PubMed ID: 16144019
    [Abstract] [Full Text] [Related]

  • 18. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP.
    Gene Ther; 2001 Apr 01; 8(7):568-78. PubMed ID: 11319624
    [Abstract] [Full Text] [Related]

  • 19. AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.
    Mohr A, Henderson G, Dudus L, Herr I, Kuerschner T, Debatin KM, Weiher H, Fisher KJ, Zwacka RM.
    Gene Ther; 2004 Mar 01; 11(6):534-43. PubMed ID: 14999225
    [Abstract] [Full Text] [Related]

  • 20. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
    Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S.
    Anticancer Res; 2001 Mar 01; 21(3B):1937-43. PubMed ID: 11497281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.